CEL-SCI Corp CVM:NYSE American

RT Quote | NYSE American | USD
Last | 4:00 PM EDT
3.04quote price arrow down-0.09 (-2.88%)
Volume
692,604
52 week range
2.49 - 27.28
Loading...
  • Open3.15
  • Day High3.15
  • Day Low2.94
  • Prev Close3.13
  • 52 Week High27.28
  • 52 Week High Date06/28/21
  • 52 Week Low2.49
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap131.72M
  • Shares Out43.33M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta2.09
  • YTD % Change-57.18

KEY STATS

  • Open3.15
  • Day High3.15
  • Day Low2.94
  • Prev Close3.13
  • 52 Week High27.28
  • 52 Week High Date06/28/21
  • 52 Week Low2.49
  • 52 Week Low Date05/12/22
  • Market Cap131.72M
  • Shares Out43.33M
  • 10 Day Average Volume0.57M
  • Dividend-
  • Dividend Yield-
  • Beta2.09
  • YTD % Change-57.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.85
  • P/E (TTM)-3.59
  • Fwd P/E (NTM)-4.75
  • EBITDA (TTM)-34.298M
  • ROE (TTM)-96.74%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-118,011.00%
  • Debt To Equity (MRQ)31.01%

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CEL-SCI Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CEL-SCI Corporation is a clinical-stage biotechnology company. The Company is focused on activating the immune system to fight cancer and infectious diseases. The Company is engaged in research and developing the treatments for cancer and other diseases by using the immune system. Its lead investigational therapy Multikine (Leukocyte Interleukin, Injection) is in a pivotal phase III clinical trial. Its Multikine is an investigational immunotherapy under development for the...
Geert Kersten Esq.
Chief Executive Officer, Treasurer, Director
Address
8229 Boone Blvd Ste 802
Vienna, VA
22182-2634
United States

Top Peers

SYMBOLLASTCHG%CHG
CTXR
Citius Pharmaceuticals Inc
0.9011-0.0138-1.5084%
ORIC
Oric Pharmaceuticals Inc
3.26-0.11-3.26%
SPPI
Spectrum Pharmaceuticals Inc
0.7392-0.0034-0.4579%
GRPH
Graphite Bio Inc
2.28UNCHUNCH
CFRX
ContraFect Corp
3.59+0.06+1.70%